Allschwil, Switzerland

Philipp Lustenberger

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Philipp Lustenberger: Innovating Autoimmune Disease Treatment**

Introduction

Philipp Lustenberger, an accomplished inventor based in Allschwil, Switzerland, has made significant contributions to the field of pharmaceutical innovations. With a keen focus on developing treatments for autoimmune diseases, his work has the potential to enhance the lives of many patients.

Latest Patents

Lustenberger holds a notable patent concerning crystalline forms of a TLR7/TLR8 inhibitor. This patent outlines various crystalline configurations of (S)—N-(4-((5-(1,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)methyl)bicyclo[2.2.2]octan-1-yl)morpholine-3-carboxamide. The patent not only discusses the free form of these crystalline structures but also elaborates on their compositions, methods of production, and various applications. Crucially, these crystalline forms provide a foundation for treating a wide range of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and psoriasis, among others.

Career Highlights

Philipp currently applies his expertise at Novartis AG, a leading global healthcare company. His focus on innovative drug development has positioned him as a key figure in advancing therapeutic solutions. With a strong educational background and substantial experience in pharmaceutical research, Lustenberger is dedicated to yielding impactful healthcare innovations.

Collaborations

Throughout his career, Lustenberger has collaborated with fellow researchers, including Nicole Bieri, further enriching his contributions to the field. This collaboration underscores the importance of teamwork in advancing complex pharmaceutical innovations.

Conclusion

Philipp Lustenberger's inventive spirit and commitment to addressing autoimmune diseases through innovative therapies mark him as a significant contributor in the pharmaceutical domain. His patent on crystalline forms of a TLR7/TLR8 inhibitor not only exemplifies his ingenuity but also holds promise for numerous patients battling autoimmune disorders. As the field of pharmacology continues to evolve, inventors like Lustenberger play a critical role in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…